We have previously reported that a similar difference in standardized log copeptin was associated with a four percent higher risk of diabetes and a two percent higher risk of incident coronary artery disease16 and that 1 SD difference in log copeptin was associated with a 31% increased risk of mortality in the MPP Cohort,13 meaning that 0.2 SD would translate to approximately six percent increased risk of mortality. Here, AVP is linked to diabetes mellitus.